Ge Ruowen
Corporate Officer/Principal presso National University of Singapore
Profilo
Ge Ruowen is the founder of ProTherapeutics Pte Ltd, which was founded in 2005.
She held the title of Scientist Officer.
Currently, she is a Principal at the National University of Singapore.
Dr. Ruowen received a doctorate degree from the University of Pennsylvania in 1992.
Posizioni attive di Ge Ruowen
| Società | Posizione | Inizio |
|---|---|---|
| National University of Singapore | Corporate Officer/Principal | 26/02/2010 |
Precedenti posizioni note di Ge Ruowen
| Società | Posizione | Fine |
|---|---|---|
ProTherapeutics Pte Ltd.
 ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Fondatore | - |
Formazione di Ge Ruowen
| University of Pennsylvania | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
ProTherapeutics Pte Ltd.
ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Health Technology |
- Borsa valori
- Insiders
- Ge Ruowen
